Iveena Delivery Systems
Manufacturing · Utah, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
391 S Chipeta Way Ste I, Salt Lake City,...Phone Number
(385) 229-4491Website
www.iveenamed.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Iveena Delivery Systems
iVeena Delivery Systems, Inc. is a clinical stage biopharmaceutical company specializing in non-surgical, non-invasive innovations for ophthalmology. The company focuses on developing disease-modifying interventions for corneal diseases and myopic conditions, addressing significant unmet medical needs. Their lead products include proprietary eye drops IVMED-80 for keratoconus and IVMED-85 for myopia. iVeena aims to provide transformative treatment options for individuals suffering from these eye conditions.Explore more
Iveena Delivery Systems Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Iveena Delivery Systems your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Iveena Delivery Systems, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Iveena Delivery Systems has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Iveena Delivery Systems has new funding data
Earning: See what the market has to say on Iveena Delivery Systems recently announced quarterly report
Product Launch: Get notified when Iveena Delivery Systems launches new products
Congratulate Masked Content for being promoted to Masked Content at Iveena Delivery Systems
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Iveena Delivery Systems had a recent Job posting/layoffs
Check out if Iveena Delivery Systems is spiking on competitors!
Recommended Actions
Find VP level buyers at Iveena Delivery Systems
Find more new buyers
Compare Similar Companies to Iveena Delivery Systems
Compare insights from companies similar to Iveena Delivery Systems, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
1960
Company Profile Activity
Activity Insights
Iveena Delivery Systems is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Iveena Delivery Systems is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Iveena Delivery Systems.
Iveena Delivery Systems Tech Stack
A closer look at the technologies used by Iveena Delivery Systems
See more technologies
Iveena Delivery Systems News & Media
iVeena Announces IND Submission to the U.S. FDA for a Phase 2 Clinical Trial for Pediatric Myopia
SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems Inc. (“iVeena”), a biopharmaceutical company advancing IVMED-85 for the treatment of pediatric myopia, today announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for IVMED-85 for the treatment of pediatric myopia. “Today’s announcement is an important milestone for iVeena in our journey to offer patients a novel therapeutic option,” said President and Founder, Bala AmbatiiVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia
SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems Inc. (“iVeena”), a biopharmaceutical company advancing IVMED-85 for the treatment of pediatric myopia, today announced that it has closed its fully subscribed Series B-2 financing of $3 million. This investment will support iVeena’s pursuit of advancing their innovative pediatric myopia program. All IND-enabling studies are well underway supporting a targeted IND submission in H1-2025. “We are pleased to welcome Dr. Jerry Hu to our BoardiVeena Awarded NEI-SBIR Grant For Progressive Myopia Drug Candidate IVMED-85
SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems Inc. (“iVeena”), a biopharmaceutical company with a developmental product in pediatric myopia is pleased to announce that Dr. Sarah Molokhia, Vice President of Research & Development for iVeena and Adjunct Assistant Professor at Department of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah, was awarded a National Eye Institute Phase 1 Small Business Innovative Research (SBIR) grant of $345,000 for iVeena’s progresBurns & Levinson Represents iVeena Delivery Systems, Inc. in Strategic Licensing Agreement with Glaukos Corporation
BOSTON, Aug. 29, 2022 /PRNewswire/ -- – Burns & Levinson is pleased to announce that it represented iVeena Delivery Systems, Inc. (iVeena), a clinical stage biopharmaceutical company with developmental products in keratoconus and pediatric myopia, in a strategic licensing agreement with...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Iveena Delivery Systems
Sign Up For FreeTo access detailed company insights
iVeena Delivery Systems, Inc. is a clinical stage biopharmaceutical company specializing in non-surgical, non-invasive innovations for ophthalmology. The company focuses on developing disease-modifying interventions for corneal diseases and myopic conditions, addressing significant unmet medical needs. Their lead products include proprietary eye dr... Read More
